Cantab Pharmaceuticals, a British biotechnology firm, has a genetically engineered vaccine now in clinical trials to protect against herpes simplex infection and reduce the recurrence of genital herpes.
ECONOMIST: Vaccines
2.
And Cantab Pharmaceuticals, a Cambridge-based biotechnology firm, has almost finished safety trials with its anti-cocaine vaccine designed to stimulate an addict's own immune system to fight off the drug, just as it might a bacterial infection.